Research is being conducted on anemia in the context of kidney disease, including its association with long-term renal prognosis and treatment options. Various studies and guidelines are being released on the topic, including those focused on chronic kidney disease and related anemia. New treatments, such as sevuparin, dapagliflozin, desidustat, and roxadustat, are being developed or approved for use in patients with anemia related to chronic kidney disease.